Fundraising

Editas Medicine

Editas Medicine Raises $118M in Follow-on Offering

2013
Founded
300+
Employees
11 Hurley Street, Cambridge, MA 02141
2 min read

Quick Facts

Editas Medicine Raises $118M in Follow-on Offering


Editas Medicine has successfully raised $118M in a Follow-on Offering at a $1.8B valuation led by Polaris Partners, Flagship Pioneering, Third Rock Ventures, Google Ventures.


Company Overview


Editas Medicine is a Biotech company headquartered in 11 Hurley Street, Cambridge, MA 02141, founded in 2013 with 300+ employees.


Genome editing medicines


Fundraising Details


  • Amount Raised: $118M
  • Round Type: Follow-on Offering
  • Valuation: $1.8B
  • Date: 2024-10-18
  • Investors: Polaris Partners, Flagship Pioneering, Third Rock Ventures, Google Ventures

About Editas Medicine


Genome editing medicines The company is positioned in the Biotech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 11 Hurley Street, Cambridge, MA 02141
  • Founded: 2013
  • Team Size: 300+
  • Industry: Biotech

What This Means


This funding round demonstrates strong investor confidence in Editas Medicine's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Editas Medicine's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1.8B valuation marks an important milestone for Editas Medicine, positioning the company among notable players in the Biotech industry.


Looking Ahead


With this new capital, Editas Medicine is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-10-18. For more information about Editas Medicine, visit their headquarters at 11 Hurley Street, Cambridge, MA 02141.

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news